Cargando…

Sodium Tanshinone II-A Sulfonate (DS-201) Induces Vasorelaxation of Rat Mesenteric Arteries via Inhibition of L-Type Ca(2+) Channel

Background: We previously have proved that sodium tanshinone II-A sulfonate (DS-201), a derivative of traditional Chinese medicinal herb Danshen (Salvia miltiorrhiza), is an opener and vasodilator of BK(Ca) channel in the vascular smooth muscle cells (VSMCs). Vascular tension is closely associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiao-Dong, He, Chun-Xia, Cheng, Jun, Wen, Jing, Li, Peng-Yun, Wang, Na, Li, Guang, Zeng, Xiao-Rong, Cao, Ji-Min, Yang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801295/ https://www.ncbi.nlm.nih.gov/pubmed/29456510 http://dx.doi.org/10.3389/fphar.2018.00062

Ejemplares similares

Tanshinone II-A sodium sulfonate (DS-201) enhances human BK(Ca) channel activity by selectively targeting the pore-forming α subunit
por: Tan, Xiao-qiu, et al.
Publicado: (2014)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
por: Zhou, Zhong-Yan, et al.
Publicado: (2020)

ET-CORM Mediated Vasorelaxation of Small Mesenteric Arteries: Involvement of Kv7 Potassium Channels
por: Zhang, Danfeng, et al.
Publicado: (2021)

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Xu, Junyao, et al.
Publicado: (2019)

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
por: Mao, Shuai, et al.
Publicado: (2019)

Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia
por: Zhong, Liren, et al.
Publicado: (2020)

Sodium tanshinone IIA sulfonate stimulated Cl(−) secretion in mouse trachea
por: Chen, Peng-Xiao, et al.
Publicado: (2017)

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
por: Guan, Ruijuan, et al.
Publicado: (2018)

In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
por: Wheal, Amanda J., et al.
Publicado: (2017)

Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro
por: Ouyang, Dong-sheng, et al.
Publicado: (2016)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model
por: Zhang, Xiao-Bin, et al.
Publicado: (2020)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK(Ca) Channels to Vasorelaxant Mechanisms
por: Iqbal, Hina, et al.
Publicado: (2021)

Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats
por: Pan, Yun, et al.
Publicado: (2017)

Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice
por: Yang, Xin-Jing, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic System
por: Xu, Qing-Qing, et al.
Publicado: (2016)

Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis
por: Xu, Jiazhen, et al.
Publicado: (2021)

Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes
por: Zhang, Wenjing, et al.
Publicado: (2017)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
por: Kan, Zunqi, et al.
Publicado: (2023)

Involvement of Potassium Channels in Vasorelaxant Effect Induced by Valeriana prionophylla Standl. in Rat Mesenteric Artery
por: Reis, Milena Ramos, et al.
Publicado: (2013)

Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts
por: Chen, Tangting, et al.
Publicado: (2018)

The mechanisms of tanshinone in the treatment of tumors
por: Zhang, Pengyu, et al.
Publicado: (2023)

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice
por: Heng, Yan-Yan, et al.
Publicado: (2023)

Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model
por: Lu, Lunjie, et al.
Publicado: (2016)

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
por: Fu, Li, et al.
Publicado: (2020)

Novel Sodium Channel Inhibitor From Leeches
por: Wang, Gan, et al.
Publicado: (2018)

Ovariectomy-Induced Reductions in Endothelial SK3 Channel Activity and Endothelium-Dependent Vasorelaxation in Murine Mesenteric Arteries
por: Yap, Fui C., et al.
Publicado: (2014)

Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza
por: Jiang, Zhouqian, et al.
Publicado: (2019)

GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K(V)7 Channel Blockers in Rat Small Mesenteric Arteries
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Vasorelaxation of goat mesenteric artery is mediated by endothelial Na(+)-K(+)-ATPase
por: Sathiskumar, R., et al.
Publicado: (2015)

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016)

Vasorelaxant Effect of Trachelospermi caulis Extract on Rat Mesenteric Resistance Arteries
por: Haam, Chae Eun, et al.
Publicado: (2022)

Glabridin-induced vasorelaxation: Evidence for a role of BK(Ca) channels and cyclic GMP
por: Chanda, Debrabata, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits
por: Ma, Shaolei, et al.
Publicado: (2018)

Sodium tanshinone IIA sulfonate protects ARPE-19 cells against oxidative stress by inhibiting autophagy and apoptosis
por: Han, Dongmei, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
por: Zhu, Ji, et al.
Publicado: (2022)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9u5ou41noeo95e27s02ftuh9t2